Interest of Tecartherapy on a Painful Caesarean Section Scar: a Randomized Clinical Trial.

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jan 20, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring the effectiveness of a treatment called Tecar therapy for women who experience pain from their cesarean section scars. After having a cesarean, about 15% of women report ongoing pain three months later, and current recommendations suggest they perform self-massage on their scars. The trial aims to see if Tecar therapy can provide better pain relief compared to a placebo treatment (a fake version that does not have any therapeutic effect). Participants will receive three sessions of either Tecar therapy or the placebo, along with instruction on how to perform self-massage.

To participate in the trial, women must be between 18 and 50 years old, have noticeable pain from their cesarean scar, and be able to provide informed consent. They will be randomly assigned to one of the two treatment groups and will complete questionnaires about their pain levels at three and six months after participating. This study is important because it may help improve the quality of life for women experiencing pain after a cesarean section and provide insights into better care options.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adult woman(≥18 years and ≤50 years), with a painful cesarean scar (VAS ≥ 4), at the 6-8 weeks postpartum visit (reimbursed by the French national health insurance fund), regardless of whether or not she is breastfeeding,
• • Capable of providing informed consent to participate in this study,
• • and affiliated with the French health insurance fund.
• Exclusion Criteria:
• • Refusal to participate,
• • Has a pacemaker or a neurostimulator,
• • Has an insulin pump,
• • Coagulation disorders,
• • Current thrombophlebitis,
• • Current pregnancy,
• • Burning sensation at the treatment area,
• • Current cancer,
• • Insensitivity to warm or to pain,
• • Current infection (tuberculosis, etc.), especially of the surgical site,
• • Current fever,
• • Bladder wound during cesarean,
• • Under guardianship or conservatorship, deprived freedom, or in the custody of correctional authorities,
• • Keloid scar from previous cesarean,
• • Previous tecar therapy,
• • Strong hypertension (systolic \> 150 or diastolic \> 100) or hypotension (systolic ≤90 and diastolic \< 40 mm Hg),
• • Dermatologic lesion in the area to be treated (eczema, psoriasis, herpes zoster, etc.),
• • subumbilical midline incision.
• • Chronic inflammatory disease.
• • Under a guardianship or conservatorship, deprived of freedom, or in the custody of correctional authorities.